IMVT
Immunovant, Inc. · Healthcare
Chief Medical Officer William L. Macias sold $250K of Immunovant, Inc.
Sold$250,360
$20.30Price
12,333Shares
−4%Stake
What IMVT did after the filing
- The stock from Fri, Aug 25 close, $20.06
- +85.6%
- S&P 500, same days
- −1.4%
Measured over 30 trading days, to the Oct 9 close.
Traded Thu, Aug 24. Filed Fri, Aug 25, 12:57 PM ET, during the session. Returns use the Aug 25 close and the Oct 9 close. Not investment advice.